Search | Biogen

Biogen to Report Fourth Quarter and Year End 2015 Financial Results on January 27, 2016

Biogen to Present at the 34th Annual J.P. Morgan Healthcare Conference

New Data Show ELOCTATE® and ALPROLIX® May Help Control Target Joint Bleeds in People with Hemophilia A and B

Form 4

Form 4

Form 4

Sobi and Biogen’s ELOCTA® (rFVIIIFc) Approved in Europe for the Treatment of Haemophilia A

Biogen Announces Benepali™ (Etanercept) is the First Biosimilar of Enbrel® to Receive a Positive Opinion from CHMP

Steven Holtzman to Retire from Biogen

Form 4